Unmet Medical Need In Treatment Of Heart Failure Patients With Atrial ... TheStreet.com (press release) ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation, heart failure and other cardiovascular diseases, today announced that the editorial “Treatment of the Heart Failure ... |
